Hudson Bay Capital Management’s Zura Bio ZURA Stock Holding History

Hudson Bay Capital Management’s Portfolio ZURA Stock Details ZURA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$567K	Buy	95,355 +32,271	+51%	+$195K	﹤0.01%	957
2025 Q4	$331K	Buy	+63,084	New	+$249K	﹤0.01%	910
2025 Q1	–	Sell	-38,999	Closed	-$113K	–	1492
2024 Q4	$113K	Hold	38,999	–	–	﹤0.01%	836
2024 Q3	$147K	Hold	38,999	–	–	﹤0.01%	756
2024 Q2	$122K	Hold	38,999	–	–	﹤0.01%	670
2024 Q1	$85.6K	Sell	38,999 -39,000	-50%	-$138K	﹤0.01%	609
2023 Q4	$325K	Buy	+77,999	New	+$390K	﹤0.01%	567
2023 Q1	–	Sell	-1,306,750	Closed	-$13.3M	–	1017
2022 Q4	$13.3M	Hold	1,306,750	–	–	0.14%	130
2022 Q3	$13.1M	Buy	1,306,750 +118,750	+10%	+$1.19M	0.12%	122
2022 Q2	$11.8M	Hold	1,188,000	–	–	0.09%	150
2022 Q1	$11.8M	Hold	1,188,000	–	–	0.16%	111
2021 Q4	$11.7M	Hold	1,188,000	–	–	0.12%	107
2021 Q3	$11.7M	Buy	+1,188,000	New	+$11.7M	0.16%	94

Other funds holding ZURA

SCM

Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return

VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

GPP

Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return

Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return

Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return

Commodore Capital New York $1.73B AUM 298.96% 1-Year Est. Return

Pfizer New York $239M AUM 232.47% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

AAA

Affinity Asset Advisors New York $1.94B AUM 374.45% 1-Year Est. Return

Hudson Bay Capital Management's ZURA Position: Q1 2026 in Review

Hudson Bay Capital Management increased its Zura Bio (ZURA) stake by 51% in Q1 2026, buying an estimated $195K and bringing the position to 95,355 shares worth $567K. The position accounts for ﹤0.01% of the portfolio, ranked #957.

Hudson Bay Capital Management first reported a position in ZURA in Q3 2021 and has held it in 13 quarters since. The position peaked at $13.3M in Q4 2022. 94 funds tracked by Wall St. Rank hold ZURA as of Q1 2026.

Hudson Bay Capital Management held 95,355 shares of Zura Bio worth $567K as of Q1 2026.
Hudson Bay Capital Management bought 32,271 Zura Bio shares in Q1 2026, an estimated $195K.
Zura Bio made up ﹤0.01% of Hudson Bay Capital Management's portfolio in Q1 2026, its #957 holding.
Hudson Bay Capital Management first reported a position in Zura Bio in Q3 2021 and has held it in 13 quarters since.
Hudson Bay Capital Management's Zura Bio position peaked at $13.3M in Q4 2022.
94 funds tracked by Wall St. Rank held Zura Bio as of Q1 2026.

Based on Hudson Bay Capital Management's 13F filing for Q1 2026, filed 13 May 2026.